Bristol-myers Squibb Compnay

Xiangdong Alan Wang

Ny Sin

Nicholas A Meanwell

Paul Michael Scola

Li-Qiang Sun

Rita Civiello

Kuo-Long Yu

Keith D Combrink

Sing-Yuen Sit

Yi Zhang

Yan Chen

Hatice Belgin Gulgeze

Andrew Charles Good

Jeffrey Allen Campbell

Brian Lee Venables

Jan Willem Thuring

Piyasena Hewawasam

Zhiwei Yin

Bradley C Pearce

Jie Chen

Christopher W Cianci

Li-Quang Sun

Yaxiong Sun

Bradley C Pearc

Hepatitis C virus inhibitors are disclosed having the general formula: 

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C virus inhibitors are disclosed having the general formula: wherein R, R, R, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C virus inhibitors are disclosed having the general formula:

The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.

Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Heterocyclic substituted 2-methyl-benzimidazole antiviral agents

The present invention concerns antiviral compounds, their compositions, and use in the treatment of viral infections. More particularly, the invention provides benzimidazolone derivatives for the treatment of respiratory syncytial virus infection.

Benzimidazolone antiviral agents

The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides imidazopyridine and imidazopyrimidine derivatives (Formula I) for the treatment of respiratory syncytial virus infection.

Imidazopyridine and imidazopyrimidine antiviral agents

Growing community of inventors

Guilford, CT, United States of America

Xiangdong Alan Wang